Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies

Chiara Citterio; Antonio Lazzaro; Costanza Bosi; Maurice De Ponzio; Luigi Cavanna

doi:10.1002/ccr3.4013

Clinical Case Reports (Jun 2021)

Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies

Chiara Citterio,
Antonio Lazzaro,
Costanza Bosi,
Maurice De Ponzio,
Luigi Cavanna

Affiliations

Chiara Citterio: Oncology and Hematology Department Oncology Unit Piacenza General Hospital Piacenza Italy
Antonio Lazzaro: Division of Hematology and Bone Marrow Transplant Center Piacenza General Hospital Piacenza Italy
Costanza Bosi: Division of Hematology and Bone Marrow Transplant Center Piacenza General Hospital Piacenza Italy
Maurice De Ponzio: Pharmacy Unit Piacenza General Hospital Piacenza Italy
Luigi Cavanna: Oncology and Hematology Department Oncology Unit Piacenza General Hospital Piacenza Italy

DOI: https://doi.org/10.1002/ccr3.4013
Journal volume & issue: Vol. 9, no. 6
pp. n/a – n/a

Abstract

Read online

Abstract Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infection, also in hematological patients.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904

About the journal

Abstract

Keywords